Join
Live feed
·
PRReleasevia Quantisnow
Abivax SA logo

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

ByQuantisnow·Wall Street's wire, on your screen.
ABVX· Abivax SA
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABVX (Abivax SA) and more on Quantisnow.